Nakissa Sadrieh

US FDA

Nakissa Sadrieh is listed at US FDA. Nakissa is scheduled to speak at SOT 66th Annual Meeting and ToxExpo 2027 on 17 March 2027.

Compiled from published conference agendas; not yet confirmed by Nakissa. Is this you? Claim this profile.

Upcoming

SOT 66th Annual Meeting and ToxExpo 2027 14 March 2027 – 17 March 2027

• Breaking the Barriers: The Evolving Regulatory Perspective on NAMs Adoption Speaker · 17 March 2027
• From Innovation to Integration: Implementing NAMs for Human Risk Assessment in Drug Discovery Toxicology Speaker · 17 March 2027

Spoke alongside

People who have shared a session with Nakissa at events on B2DB.

• Amy Mihalchik ToxStrategies LLC 1 shared session
• Kimberley Homan Genentech Inc. 1 shared session
• Philip Hewitt Merck & Co. Inc. 1 shared session
• Wenyue (Wendy) Hu Vividion Therapeutics 1 shared session
• Will Proctor GSK 1 shared session